配方开发,优化和评价的味道掩盖的药物糖的塞特拉林的配方开发,优化和评价
Prerna Kaushik1, Vineet Mittal1, Deepak Kaushik1
1Department of Pharmaceutical Sciences, M.D. University, Rohtak, India.
Therapeutic delivery
|May 21, 2025
概括
这项研究开发了使用Sertraline-cyclodextrin包容复合物的口味掩饰药物牙. 这种新的口香糖配方与传统药片相比,提供了更好的口感和药物释放.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 制定 发展 制定 发展
背景情况:
- 患者的服药性和可口性是传统口服剂型的重大挑战,特别是对于像塞特拉林这样的苦味药物.
- 药用口香糖提供了一个有前途的替代品,可以改善患者的药物坚持和药物管理.
- 环氧德克斯含复合物有效地掩盖了苦味的活性药物成分的味道.
研究的目的:
- 开发和描述含有塞特拉林-环德克斯综合体的口味掩饰药物口香糖.
- 为了提高患者对塞特拉林药物的遵从性和可口性.
- 评估开发的口香糖配方的药物释放特征和口腔透.
主要方法:
- 使用制方法制备了塞特拉林 - 环德林入复合物.
- 使用E-Tongue系统评估了口味掩饰的有效性.
- 药用口香糖是使用直接可压缩的口香糖基制成的,并通过中央复合设计进行优化.
- 牙经过了全面的评估,包括重量变化,药物含量,硬度,体外溶解,体外口腔透,稳定性测试和质地分析.
主要成果:
- "电子舌头"证实了环氧在掩盖味道的Sertraline中的有效性.
- 优化的口香糖配方表现出硬度为4.1 ± 0.88 kg/cm2和80.6 ± 0.65%的药物释放率.
- 在ex-vivo口腔研究中观察到显著的药物透.
- 实验设计表明,塑化剂和基含量影响了硬度和体外药物释放.
结论:
- 装有塞特拉林 - 环氧德克斯综合体的口味掩饰药物,是传统药片配方的优质替代品.
- 这种创新的剂型提高了药物释放特征和可口性,可能提高患者的服药性.
- 开发的口香糖配方显示Sertraline有效口服的承诺.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
111
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
111
Taste Buds and Receptors
1.8K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
1.8K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
138
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
138
Drug Delivery: Enteral Route
360
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
360
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
201
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
201
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
272
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
272


